Neville Pharmaceutical, Inc.
Records under this name other than patents Neville Pharmaceutical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Neville Pharmaceutical, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,795,598 | Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvenation Lapsed on the fee record Ended Oct 24, 2021 · USPTO record | Lapsed on the fee record | Ended Oct 24, 2021 | USPTO record |
| US 9,549,960 | Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvination Lapsed on the fee record Ended Jan 24, 2021 · USPTO record | Lapsed on the fee record | Ended Jan 24, 2021 | USPTO record |
| US 9,439,940 | Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation Lapsed on the fee record Ended Sep 13, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 13, 2020 | USPTO record |
| US 9,265,741 | Molecules to perfect HbA1c levels Lapsed on the fee record Ended Feb 23, 2020 · USPTO record | Lapsed on the fee record | Ended Feb 23, 2020 | USPTO record |
| US 9,254,250 | Molecules to perfect HbA1c levels Lapsed on the fee record Ended Feb 9, 2020 · USPTO record | Lapsed on the fee record | Ended Feb 9, 2020 | USPTO record |